Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jordan E. Lake, MD, MSc
Houston AIDS Research Team CRS
Study Chair - Kristine Erlandson, MD, MS
University of Colorado Hospital CRS
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto de Pesquisa Clinica Evandro Chagas (ipec) Crs (site Id: 12101)
Rio de Janeiro, Brazil
- Alabama Crs (site Id: 31788)
Birmingham, Alabama, United States
- University of Colorado Hospital Crs (site Id: 6101)
Aurora, Colorado, United States
- Johns Hopkins University Crs
Baltimore, Maryland, United States
- Massachusetts General Hospital Crs (mgh Crs) (site Id: 101)
Boston, Massachusetts, United States
- Cincinnati Clinical Research Site (site Id: 2401)
Cincinnati, Ohio, United States
- Ohio State University Crs (site Id: 2301)
Columbus, Ohio, United States
- Houston Aids Research Team Crs (site Id: 31473)
Houston, Texas, United States
- University of Washington Aids Crs (site Id: 1401)
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Feb 2021
- Primary completion
- 16 Mar 2023
- Completion
- 15 Sept 2023
- Last update posted
- 1 Oct 2024
- Registered enrollment
- 51
- Registry id
- NCT04216589
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.